Daxor Market Cap 2010-2011 | DXR

Daxor market cap history and chart from 2010 to 2011. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Daxor market cap as of January 13, 2025 is $0.04B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.040B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.128B 0.00
Quest Diagnostics (DGX) United States $16.942B 17.17
DaVita (DVA) United States $12.579B 16.27
Encompass Health (EHC) United States $9.173B 21.63
Chemed (CHE) United States $7.854B 24.14
Elanco Animal Health (ELAN) United States $5.650B 13.45
RadNet (RDNT) United States $5.092B 112.75
Option Care Health (OPCH) United States $4.083B 19.35
Amedisys (AMED) United States $3.010B 21.42
LifeStance Health (LFST) United States $2.958B 0.00
Addus HomeCare (ADUS) United States $2.273B 26.67
Astrana Health (ASTH) United States $1.658B 22.68
U.S Physical Therapy (USPH) United States $1.313B 34.52
Pennant (PNTG) United States $0.887B 35.86
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00